| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOPSYCH.2005.02.008 |
| P698 | PubMed publication ID | 15992524 |
| P2093 | author name string | David L Garver | |
| James D Christensen | |||
| Jennifer A Holcomb | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 62-66 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Cerebral cortical gray expansion associated with two second-generation antipsychotics | |
| P478 | volume | 58 |
| Q36692829 | A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. |
| Q38955981 | A neuroimaging study of emotion-cognition interaction in schizophrenia: the effect of ziprasidone treatment |
| Q24236683 | Antipsychotic medication for early episode schizophrenia |
| Q51886464 | Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia. |
| Q26786253 | Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review |
| Q33592537 | Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss |
| Q30482440 | Cortical grey matter volume and sensorimotor gating in schizophrenia |
| Q82768112 | Designing outcome studies to determine efficacy and safety of antipsychotics for 'real world' treatment of schizophrenia |
| Q42108290 | Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia |
| Q35550905 | Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis |
| Q33425487 | Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings |
| Q48960835 | Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. |
| Q37480943 | Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia |
| Q39248594 | Extrastriatal dopamine D2/3 receptors and cortical grey matter volumes in antipsychotic-naïve schizophrenia patients before and after initial antipsychotic treatment |
| Q64039164 | From Clinical Research to Clinical Practice: A 4-Year Review of Ziprasidone |
| Q40277970 | In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia |
| Q35199663 | Inferior parietal lobule volume and schneiderian first-rank symptoms in antipsychotic-naïve schizophrenia: a 3-tesla MRI study |
| Q36024427 | Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings |
| Q45789895 | Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response |
| Q34351095 | Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. |
| Q48194093 | Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia |
| Q35898965 | Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment? |
| Q37727085 | Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients |
| Q34279073 | The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions |
| Q31120604 | The effects of antipsychotic treatment on cerebral structure and function in schizophrenia |
| Q96773916 | The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia |
| Q31038084 | Understanding structural brain changes in schizophrenia |
| Q33785978 | Updated report on tools to measure outcomes of clinical trials in fragile X syndrome |
| Q31048455 | Use of magnetic resonance imaging in tracking the course and treatment of schizophrenia |
| Q87945859 | [Frontal brain volume reduction due to antipsychotic drugs?] |
Search more.